Bridge to Life Chairman & CEO Stevan Schweighardt was interviewed in a feature piece for CEOCFO Magazine. He discusses the challenges of the transplant field and Bridge to Life’s current and upcoming solutions to make organ transplantations more successful.
“Bridge to Life is now an international company, providing organ preservation solutions to over 50 countries. We lead the worldwide market for transplant solutions and have been providing our Belzer UW® and Belzer MPS® solutions for over 12 years. Bridge to Life continues to research and develop technology to improve organ preservation and have now added organ perfusion devices to our portfolio of products. The addition of perfusion technology provides for more and better-quality organs to the transplant community worldwide.”
– Stevan Schweighardt
